Skip to main content
. Author manuscript; available in PMC: 2013 May 24.
Published in final edited form as: Vaccine. 2010 Mar 1;28(18):3106–3111. doi: 10.1016/j.vaccine.2010.02.063

Figure 2.

Figure 2

Figure 2

Figure 2

Serum and fecal antibody profiles of mice intranasally inoculated with SA11 NSP4 and either tetanus toxoid (TT) or ovalbumin (OVA). Animals (n=5) were administered with model antigen alone, co-administered with full-length NSP4 or with mLT as an immunostimulatory control. Samples were collected 14 days post final inoculation and assayed by ELISA. Panel (a) shows the KLH-specific serum IgG and total immunoglobulin results in Geometric Mean Titers (GMT), panel (b) shows the level of KLH-specific fecal IgA responses, panel (c) shows OVA-specific serum IgG levels and panel (d) shows OVA-specific IgA fecal levels among the various immunized groups of mice.